Edition:
United Kingdom

Corvus Pharmaceuticals Inc (CRVS.OQ)

CRVS.OQ on NASDAQ Stock Exchange Global Market

10.56USD
20 Apr 2018
Change (% chg)

$-0.09 (-0.85%)
Prev Close
$10.65
Open
$10.65
Day's High
$11.06
Day's Low
$10.53
Volume
21,323
Avg. Vol
40,495
52-wk High
$17.54
52-wk Low
$7.45

Latest Key Developments (Source: Significant Developments)

Corvus Pharmaceuticals Announces Closing Of Public Offering Of Common Stock
Monday, 12 Mar 2018 

March 12 (Reuters) - Corvus Pharmaceuticals Inc ::CORVUS PHARMACEUTICALS ANNOUNCES CLOSING OF PUBLIC OFFERING OF COMMON STOCK.  Full Article

Corvus Pharmaceuticals reports third quarter 2017 financial results
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Corvus Pharmaceuticals Inc ::Corvus Pharmaceuticals reports third quarter 2017 financial results and clinical program update.Net loss for three months ended September 30, 2017, was $12.7 million compared to $10.3 million for same period in 2016​.  Full Article

Corvus Pharma qtrly loss per share $0.43
Thursday, 4 Aug 2016 

Corvus Pharmaceuticals Inc : Corvus pharmaceuticals announces second quarter financial results and provides business update . Q2 earnings per share view $-0.36 -- Thomson Reuters I/B/E/S .Qtrly loss per share $0.43.  Full Article

BRIEF-Adams Street Partners Reports 15.5 Pct Stake In Corvus Pharma

* ADAMS STREET PARTNERS, LLC REPORTS 15.5 PERCENT STAKE IN CORVUS PHARMACEUTICALS INC AS OF MARCH 12, 2018 - SEC FILING‍​